Mergers and Acquisitions

Takeda’s $62bn Shire acquisition is a go following shareholder votes

06-Dec-2018 By Maggie Lynch

Takeda will takeover Shire, after shareholders approved the proposed acquisition, and is expected to close in early 2019.

GSK rebuilds oncology pipeline with $5.1bn acquisition

04-Dec-2018 By Maggie Lynch

GSK entered an agreement with Tesaro to gain ‘under-appreciated’ PARP inhibitor assets and a Boston base.

Unilever to acquire Horlicks and GSK’s Health Food Drinks portfolio

04-Dec-2018 By Rachel Arthur

Unilever will acquire GlaxoSmithKline’s Health Food Drinks portfolio in Asia for €3.3bn ($3.8bn): a move that will boost its presence in the Indian market.

Bayer to shed €600m factor VIII facility and 12,000 staff

30-Nov-2018 By Ben Hargreaves

Bayer looks to boost investor confidence by cutting away its animal health unit, selected consumer health brands and a number of jobs to focus on its life sciences businesses.

Sun Pharma buys Japanese drugmaker with two manufacturing sites

27-Nov-2018 By Flora Southey

Sun Pharma has announced plans to acquire Pola Pharma for $1m, adding topical drug and injectables manufacturing capabilities to its network in Japan.

Cambrex acquires Avista for $252m, becomes integrated CDMO

21-Nov-2018 By Maggie Lynch

Cambrex is set to acquire Avista and enter the market of early stage small molecule development and testing.

European regulators approve Takeda’s acquisition of Shire after divestment

21-Nov-2018 By Maggie Lynch

Takeda’s aim to acquire Shire for $62bn received a boost after regulators vote positively to approve the transaction following the divestment of Shire’s IBD drug.

NEWS IN BRIEF

Tekni-Plex enhances packaging capabilities with tenth acquisition

15-Nov-2018 By Ben Hargreaves

The US company said the acquisition was in line with its 'strategy to grow its business through transformative acquisitions and strategic add-ons.'

NEWS IN BRIEF

Ardena: M&A growth fuels HQ expansion

14-Nov-2018 By Flora Southey

CDMO Ardena has moved into larger headquarters in Gent, Belgium, to “free up space for additional laboratories”, says CEO.

Takeda to vote on $62bn Shire acquisition, looming debt a factor

13-Nov-2018 By Maggie Lynch

Takeda Pharmaceutical will hold an investor vote next month on the $62bn acquisition of rare disease specialist, Shire.

Takeda proposes sale of IBD pipeline to close Shire deal

31-Oct-2018 By Maggie Lynch

Takeda is in talks to sell Shire’s experimental inflammatory bowel disease pipeline in an effort to meet European regulators approval for the acquisition.

2018: The year that pharma got its house in order

29-Oct-2018 By Ben Hargreaves

This year a number of companies made big moves to divest certain parts of their portfolios, but why has it been such a significant year for this?

Pfizer taps Bain Capital for $350m to create neuro-focused biotech

24-Oct-2018 By Maggie Lynch

Pfizer has entered into an investment agreement with Bain Capital to spinout its neuroscience portfolio into a jointly-led company.

Novartis spends $2.1bn on candidate with blockbuster potential

23-Oct-2018 By Maggie Lynch

Novartis will acquire Endocyte for $2.1bn, with the core of the deal centering on the latter’s experimental therapy for prostate cancer.

Dr. Reddy’s sells Tennessee antibiotic manufacturing site

08-Oct-2018 By Maggie Lynch

Dr. Reddy’s Laboratories antibiotic manufacturing site in Bristol, Tennessee, has been sold to Neopharma, along with all issued and outstanding membership interests and related assets.